Immunovia successfully completes discovery phase of next-generation test development

Contributed by: PR Newswire

Tags

Immunovia-AB

More Like This

Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test

Immunovia completes development of its pancreatic cancer detection test after substantially increasing test accuracy

Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study

Immunovia files US patent application to protect its next-generation test

Immunovia completes analytical validation of its next-generation pancreatic cancer test

Immunovia presents data from discovery study at 2024 PancreasFest medical conference

Immunovia presents data from model development study at 2024 AACR Advances in Pancreatic Cancer medical conference

Immunovia has successfully acquired all blood samples required to clinically validate its next-generation test for pancreatic cancer